Zomedica Corp. (ZOM)

Zomedica Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	25.19	18.93	4.13	0	0
Revenue Growth (YoY)	33.05%	358.02%	-	-	-
Cost of Revenue	7.87	5.46	1.08	0	0
Gross Profit	17.32	13.47	3.05	0	0
Selling, General & Admin	43.17	32.81	22.76	8.72	6.99
Research & Development	5.74	2.58	1.67	8.04	10.35
Other Operating Expenses	11.66	-0	0.25	0.12	2.46
Operating Expenses	60.57	35.39	24.68	16.89	19.79
Operating Income	-43.25	-21.92	-21.62	-16.89	-19.79
Interest Expense / Income	0.18	0	0.01	0	0.02
Other Expense / Income	-8.46	-1.7	-0.91	0.03	-0.02
Pretax Income	-34.97	-20.23	-20.72	-16.91	-19.78
Income Tax	-1.33	-2.37	-2.33	0	0
Net Income	-33.64	-17.86	-18.38	-16.91	-19.78
Shares Outstanding (Basic)	980	980	957	364	106
Shares Outstanding (Diluted)	980	980	957	364	106
Shares Change	-	2.45%	162.46%	242.85%	13.76%
EPS (Basic)	-0.04	-0.02	-0.05	-0.05	-0.19
EPS (Diluted)	-0.04	-0.02	-0.05	-0.05	-0.19
Free Cash Flow	-27.31	-14.22	-14.42	-16.23	-15.79
Free Cash Flow Per Share	-0.03	-0.01	-0.01	-0.04	-0.15
Gross Margin	68.76%	71.15%	73.89%	-	-
Operating Margin	-171.73%	-115.81%	-523.18%	-	-
Profit Margin	-133.56%	-94.35%	-444.76%	-	-
Free Cash Flow Margin	-108.45%	-75.12%	-348.97%	-	-
EBITDA	-33.96	-19.8	-20.44	-16.61	-18.98
EBITDA Margin	-134.85%	-104.59%	-494.65%	-	-
Depreciation & Amortization	0.83	0.43	0.27	0.31	0.79
EBIT	-34.79	-20.23	-20.71	-16.91	-19.77
EBIT Margin	-138.15%	-106.84%	-501.06%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).